APPL1 and osteoporosis: In this study, we demonstrated that APPL1 reduced glucocorticoid-induced bone loss by promoting osteogenic differentiation of MSCs in vivo, and we emphasized that our animal model of osteoporosis can be used to investigate osteogenic differentiation of osteoporosis.